Ginkgo Bioworks Holdings, Inc.DNANYSE
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-382.13M
↓ 44% below average
Average (5y)
$-265.63M
Historical baseline
Range
High:$-66.88M
Low:$-382.13M
CAGR
+41.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-382.13M | -13.6% |
| 2023 | $-336.30M | -10.5% |
| 2022 | $-304.47M | +1.9% |
| 2021 | $-310.34M | -60.3% |
| 2020 | $-193.65M | -189.5% |
| 2019 | $-66.88M | - |